Statistics in Medicine 2012-09-20

A smoothing expectation and substitution algorithm for the semiparametric accelerated failure time frailty model.

Lynn M Johnson, Robert L Strawderman

Index: Stat. Med. 31(21) , 2335-58, (2012)

Full Text: HTML

Abstract

This paper proposes an estimation procedure for the semiparametric accelerated failure time frailty model that combines smoothing with an Expectation and Maximization-like algorithm for estimating equations. The resulting algorithm permits simultaneous estimation of the regression parameter, the baseline cumulative hazard, and the parameter indexing a general frailty distribution. We develop novel moment-based estimators for the frailty parameter, including a generalized method of moments estimator. Standard error estimates for all parameters are easily obtained using a randomly weighted bootstrap procedure. For the commonly used gamma frailty distribution, the proposed algorithm is very easy to implement using widely available numerical methods. Simulation results demonstrate that the algorithm performs very well in this setting. We re-analyz several previously analyzed data sets for illustrative purposes.Copyright © 2012 John Wiley & Sons, Ltd.


Related Compounds

Related Articles:

In vitro and in vivo evaluation of novel osmotic pump tablets of isosorbide-5-mononitrate containing polyvinyl pyrrolidone (PVP) for controlled release.

2012-08-01

[Pharmazie 67(8) , 695-700, (2012)]

Superoxide dismutases, SOD1 and SOD2, play a distinct role in the fat body during pupation in silkworm Bombyx mori.

2015-01-01

[PLoS ONE 10(2) , e0116007, (2015)]

Early administration of isosorbide dinitrate improves survival of cyanide-poisoned rabbits.

2015-01-01

[Clin. Toxicol. (Phila.) 53(1) , 22-7, (2015)]

Headache response to nitrate in patients with coronary artery disease and systolic heart failure

2012-07-26

[Int. J. Cardiol. 158(3) , 453-4, (2012)]

A randomized phase II study of irinotecan plus cisplatin versus irinotecan plus capecitabine with or without isosorbide-5-mononitrate in advanced non-small-cell lung cancer.

2012-11-01

[Ann. Oncol. 23(11) , 2925-30, (2012)]

More Articles...